Jameela Al Salman
Jameela Al Salman is a prominent Bahraini infectious disease specialist and a key figure in the healthcare sector of Bahrain. She has played a significant role in managing and controlling infectious diseases within the country, particularly during the COVID-19 pandemic.
Early Life and Education[edit | edit source]
Jameela Al Salman was born and raised in Bahrain. She pursued her medical education at the Arabian Gulf University, where she earned her medical degree. She further specialized in infectious diseases, completing her residency and fellowship in the field.
Career[edit | edit source]
Dr. Al Salman has had a distinguished career in the medical field, with a focus on infectious diseases. She has held various positions in Bahrain's healthcare system, contributing to the development and implementation of strategies to combat infectious diseases.
COVID-19 Pandemic[edit | edit source]
During the COVID-19 pandemic, Dr. Al Salman emerged as a leading figure in Bahrain's response to the crisis. She was instrumental in the establishment of protocols for testing, treatment, and vaccination. Her efforts were crucial in managing the spread of the virus and ensuring the healthcare system's resilience.
Contributions and Achievements[edit | edit source]
Dr. Al Salman has been recognized for her contributions to the field of infectious diseases. She has published numerous research papers and has been a speaker at various international conferences. Her work has significantly impacted public health policies in Bahrain.
Personal Life[edit | edit source]
Details about Dr. Al Salman's personal life are not widely publicized. She is known to be dedicated to her profession and committed to improving public health in Bahrain.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD